Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

Net income in the fiscal third quarter was $15.6 million (or 26 cents a share), down 26% on a year-over-year basis, primarily due to lower software license sales.

Revenues

Revenues increased 2% year over year to $114.5 million in the fiscal third quarter. The company’s revenues missed the Zacks Consensus Estimate of $119 million.

Segment-wise Results

System sales amounted to $29.2 million, down about 29.9% year over year. Revenues from the two subcomponents were $21.9 million (down 37.6% year over year) from Software, Hardware and Supplies and $7.3 million (up 10.8% on a year-over-year basis) from Implementation and Training Services.

Revenues from Maintenance, Electronic Data Interchange Services (EDI), Revenue Cycle Management and other Services amounted to $85.3 million, up 20% year over year. Segment sales are reported under four separate headings. Maintenance revenues came in at $39.5 million, up 8.9% year over year. Electronic data interchange services revenues were $15.2 million, up 25.7% year over year. Revenue Cycle Management sales surged 34.7% year over year to $15 million and revenues from other services amounted to $15.6 million, up 34.5% year over year.

Margin

Gross margin declined to 59.3% in the fiscal third quarter compared to 66% in the prior-year quarter. Operating margin dropped to roughly 20.4% from 28.8% in the year-ago quarter. The decline in margin is due to reduction in the high-margin System sales in the reported quarter.

The selling, general and administrative expenses climbed 7.4% year over year to $35.5 million in the quarter while research and development expenditure declined 5.9% year over year to $7.8 million.

Balance Sheet

Quality Systems ended the fiscal third quarter with cash, cash equivalents and marketable securities of $106.9 million, down 17.9% year over year.

Our Take

Quality Systems runs a pure-play business model in an attractive industry with a large number of catalysts, which provoke frequent speculation about mergers and acquisitions. On the positive side, we observe the high proportion of recurring revenues. Of late, however, growth of its pipeline metric has seen a falling trend.

The company has made multiple acquisitions to bolster organic growth. Its acquisitions are expected to facilitate its entry in the small hospital segment. We are concerned about execution risk emanating from Quality Systems’ entry into the rural inpatient market.

Quality Systems has traditionally focused on providing solutions for physician practices. However, core ambulatory EHR providers such as Quality Systems will see opportunities for product sales shrink, as physician groups are increasingly absorbed into hospitals.

Resources

Client Support

Follow Us

Zacks Research is Reported On:

Yahoo

MSN

Marketwatch

Nasdaq

Forbes

Investors.com

Morningstar

Zacks Investment Research is an A+ Rated BBB Accredited Business.

Copyright 2016 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1988-2015 and were examined and attested by Baker Tilly Virchow Krause, LLP, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.